Our Team

Each Partner brings extensive industry knowledge, unrivaled relationships and substantial deal experience, resulting in a team of the industry's most sought after advisors

Joshua D. Thornton

Partner
 
Josh Thornton is a founding member of the Healthcare practice at Centerview Partners.  He is an experienced advisor to senior management teams and boards of public and private life sciences companies. Over the course of his career he has engaged with life sciences clients across biopharma, medical devices, diagnostics and tools on a broad range of complex strategic and financial issues and transactions, including mergers, acquisitions, divestitures, partnerships, defense, and debt and equity financings.

Mr. Thornton’s notable transactions include Pfizer’s $68 billion acquisition of Wyeth, InterMune’s $8.9 billion sale to Roche, AveXis’ $8.7bn sale to Novartis, Receptos’ $7.8 billion sale to Celgene; OSI Pharmaceuticals’ $4.0 billion sale to Astellas Pharma, Thoratec’s $3.7 billion sale to St. Jude Medical; Avanir’s $3.5 billion sale to Otsuka; Biogen Idec’s $3.25+ billion acquisition of full rights and control of Tysabri from Elan; Pacific Biosciences’ $1.3 billion sale to Illumina; MAP Pharmaceuticals’ $958 million sale to Allergan; Bioverativ’s acquisition of True North Therapeutics for up to $825mm, Haemonetics’ $551 million acquisition of assets from Pall Corporation; XenoPort’s $457mm sale to Arbor Pharmaceuticals, Ultragenyx’s $151mm acquisition of Dimension Therapeutics, Dendreon Corporation’s sale of a royalty interest to CPPIB, and Cytokinetics’s sale of a royalty interest to Royalty Pharma.

Mr. Thornton joined Centerview in 2009 from Merrill Lynch where he worked in the Mergers & Acquisitions Group. He holds an M.B.A. from the Stern School of Business at New York University and a B.A. in Economics/East Asian Studies from Wesleyan University.

He lives in San Francisco with his wife and three kids.
Centerview Partners takes a “One Firm” approach to deliver unmatched intellectual capital and integrity to all of our clients. We have industry-leading expertise in:

Centerview is honored to partner with leading charitable organizations in active support of our charities:

  • Arts Connection
  • NY Cares
  • Bottomless Closet
Blackhawk Mining LLC
Announced: Q3 2019
Value: $1.1 billion
Status: Pending

Investment banker and financial advisor to Blackhawk on its RSA and Chapter 11 filing
View All
New York

Centerview Partners LLC
31 West 52nd Street
22nd Floor
New York, New York 10019

(212) 380-2650 | Tel
(212) 380-2651 | Fax
London

Centerview Partners UK LLP
100 Pall Mall
3rd Floor
London SW1Y 5NQ,

02074099700 | Tel
02074099704 | Fax
San Francisco

Centerview Partners LLC
555 California Street
Suite 4300
San Francisco, CA 94104

(415) 400-0900 | Tel
(415) 400-0901 | Fax
Los Angeles

Centerview Partners LLC
1999 Avenue of the Stars
Suite 3030
Los Angeles, CA 90067

(424) 230-5950 | Tel
(424) 230-5951 | Fax
Palo Alto

Centerview Partners LLC
600 Ramona St.
Suite 300
Palo Alto, California 94301

(650) 822-5800 | Tel
(650) 822-5801 | Fax

Copyright © 2008 - 2019 Centerview Partners Holdings LP. All Rights Reserved. | Privacy and Other Notices

Centerview Partners LLC, member SIPC